Drug & Medication Database

Dosage form: POWDER. Active ingredients: ELAMIPRETIDE (1 g/g). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: ELAMIPRETIDE (1 g/g). Category: BULK INGREDIENT.

11 DESCRIPTION FORZINITY contains elamipretide, a mitochondrial cardiolipin binder. Elamipretide is isolated as a hydrochloride salt that is freely soluble in water. The chemical name for elamipretide hydrochloride is L-Phenylalaninamide, D-arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-, hydrochloride (1:3). Its molecular formula is C 32 H 49 N 9 O 5 ∙3HCl and its molecular weight is 749.2.

Brands: Forzinity

11 DESCRIPTION Elapegademase-lvlr is a recombinant adenosine deaminase (rADA) based on bovine amino acid sequence, conjugated to monomethoxypolyethylene glycol (mPEG). rADA is manufactured in E. coli and is covalently conjugated to mPEG with a succinimidyl carbamate linker to produce methoxypolyethylene glycol recombinant adenosine deaminase (SC-PEG rADA). The approximate molecular weight of elapegademase-lvlr (SC-PEG rADA) is 113 KDa.

Brands: Revcovi

OTC - PURPOSE SECTION Formulated for associated symptoms such as enlarged or bleeding hemorrhoidal veins, itching, inflammation, burning pain and pressure.

Brands: Hemorrhoids

OTC - PURPOSE SECTION Formulated for associated symptoms such as hot flashes, decreased libido, sleeplessness, mood swings, discomfort and fatigue.

Brands: Menopause

OTC - PURPOSE SECTION Formulated for associated symptoms such as dryness, itching, hearing difficulties and excess wax accumulation.

Brands: Ear Wax Build-up

OTC - PURPOSE SECTION Formulated for symptoms such as skin discoloration, discomfort and swelling.

Brands: Edema

Homeopathic combination product formulated for associated symptoms such as throbbing pain, pressure, congestion, dizziness, nausea and light sensitivity.

Brands: Headache

OTC - PURPOSE SECTION Formulated for associated symptoms such as enlarged veins, swelling, discoloration, pain, stinging and heaviness in the legs.

Brands: Varicose Veins

Dosage form: POWDER. Active ingredients: ELBASVIR (1 kg/kg). Category: BULK INGREDIENT.

11 DESCRIPTION ZEPATIER is a fixed-dose combination tablet containing elbasvir and grazoprevir for oral administration. Elbasvir is an HCV NS5A inhibitor, and grazoprevir is an HCV NS3/4A protease inhibitor. Each tablet contains 50 mg elbasvir and 100 mg grazoprevir.

Brands: Zepatier

Dosage form: POWDER. Active ingredients: ELBASVIR (20 kg/100kg). Category: DRUG FOR FURTHER PROCESSING.

Purpose External analgesic External analgesic

Brands: Menthol And Methyl Salicylate

Eletriptan hydrobromide tablets contain eletriptan hydrobromide, which is a selective 5-hydroxytryptamine 1B/1D (5-HT1B/1D) receptor agonist. Eletriptan hydrobromide is chemically designated as (R)-3-[(1-Methyl-2-pyrrolidinyl)methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-indole monohydrobromide, and it has the following chemical structure: [Chemical Structure] The molecular formula is C22H26N2O2S . HBr, representing a molecular weight of 463.43.

Brands: Eletriptan Hbr

Prescription triptan medication indicated for the acute treatment of migraine with or without aura in adults.

Brands: Eletriptan Hydrobromide

Dosage form: POWDER. Active ingredients: ELETRIPTAN HYDROBROMIDE (1 kg/kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: ELETRIPTAN HYDROBROMIDE (100 kg/100kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: ELETRIPTAN HYDROBROMIDE MONOHYDRATE (1 kg/kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: ELEXACAFTOR (1 kg/kg). Category: BULK INGREDIENT.

Dosage form: TABLET, COATED. Active ingredients: ELEXACAFTOR (100 mg/1); IVACAFTOR (75 mg/1); TEZACAFTOR (50 mg/1). Category: DRUG FOR FURTHER PROCESSING.

11 DESCRIPTION TRIKAFTA is a co-package of elexacaftor, tezacaftor and ivacaftor fixed-dose combination tablets or granules and ivacaftor tablets or granules. Both tablets and granules are for oral administration.

Brands: Trikafta

11 DESCRIPTION CERDELGA (eliglustat) capsules contain eliglustat tartrate, which is a small molecule inhibitor of glucosylceramide synthase that resembles the ceramide substrate for the enzyme, with the chemical name N-((1 R ,2 R )-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)octanamide (2 R ,3 R )-2,3-dihydroxysuccinate.

Brands: Cerdelga

Dosage form: POWDER. Active ingredients: ELIGLUSTAT TARTRATE (1 kg/kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: ELIGLUSTAT TARTRATE (1 kg/kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: ELIGLUSTAT TARTRATE (1 kg/kg). Category: BULK INGREDIENT.

11 DESCRIPTION LYNKUET is an NK1 and NK3 receptor antagonist. The chemical name of elinzanetant is 2-[3,5-bis(trifluoromethyl)phenyl]-N-{4-(4-fluoro-2-methylphenyl)-6-[(7S,9aS)-7-(hydroxymethyl)hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl]pyridin-3-yl}-N,2-dimethylpropanamide having a molecular formula of C 33 H 35 F 7 N 4 O 3 and a molecular weight of 668.7.

Brands: Lynkuet

11 DESCRIPTION SKYSONA (elivaldogene autotemcel) is an autologous HSC-based gene therapy prepared from the patient's HSCs, which are collected via apheresis procedure(s). The autologous cells are enriched for CD34+ cells, then transduced ex vivo with Lenti-D LVV, and cultured with growth factors overnight. Lenti-D LVV is a replication-incompetent, self-inactivating LVV carrying ABCD1 cDNA that encodes normal ALDP.

Brands: Skysona

Dosage form: INJECTION, SOLUTION. Route: SUBCUTANEOUS. Active ingredients: ULMUS AMERICANA POLLEN (.05 g/mL). Category: BLA.

Brands: Ulmus Americana Pollen

Dosage form: INJECTION, SOLUTION. Route: SUBCUTANEOUS. Active ingredients: ULMUS CRASSIFOLIA POLLEN (.05 g/mL). Category: BLA.

Brands: Ulmus Crassifolia Pollen